Cytecare Hospitals Profile
Key Indicators
- Authorised Capital ₹ 2.73 Cr
as on 27-12-2024
- Paid Up Capital ₹ 4.34 M
as on 27-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 38.44 Cr
as on 27-12-2024
- Satisfied Charges ₹ 15.00 Cr
as on 27-12-2024
- Revenue 5.98%
(FY 2021)
- Profit 31.89%
(FY 2021)
- Ebitda 25.04%
(FY 2021)
- Net Worth 35.48%
(FY 2021)
- Total Assets -0.58%
(FY 2021)
About Cytecare Hospitals
The Corporate was formerly known as Medela Hospitals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.73 Cr and a paid-up capital of Rs 4.34 M.
The company currently has active open charges totaling ₹38.44 Cr. The company has closed loans amounting to ₹15.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ferzaan Engineer, Himanshu Shah, Suresh Ramu, and Seven other members serve as directors at the Company.
- CIN/LLPIN
U85110GJ2014PTC079078
- Company No.
079078
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2014
- Date of AGM
13 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cytecare Hospitals?
Board Members(10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Ramu  | Director | 11-Mar-2014 | Current |
Shikar Nensey  | Director | 15-Sep-2015 | Current |
Ravi Achar  | Director | 27-Nov-2015 | Current |
Gillian Corken  | Director | 15-Sep-2015 | Current |
Gerardus Hoogland  | Director | 15-Sep-2015 | Current |
| Ferzaan Engineer | Director | 15-Jun-2014 | Current |
Financial Performance of Cytecare Hospitals.
Cytecare Hospitals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 5.98% increase. The company also saw a substantial improvement in profitability, with a 31.89% increase in profit. The company's net worth Soared by an impressive increase of 35.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cytecare Hospitals?
In 2021, Cytecare Hospitals had a promoter holding of 6.27% and a public holding of 93.72%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Canadian Global Life And Educare Private LimitedActive 12 years 6 monthsAjitkumar Rampure is a mutual person
Sun Pharma Advanced Research Company LimitedActive 18 years 10 monthsFerzaan Engineer is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Sep 2024 | ₹5.00 Cr | Open |
Hdfc Bank Limited Creation Date: 14 Mar 2024 | ₹5.78 M | Open |
Standard Chartered Bank Creation Date: 01 Mar 2024 | ₹6.50 M | Open |
How Many Employees Work at Cytecare Hospitals?
Cytecare Hospitals has a workforce of 259 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cytecare Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytecare Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
